Page 11 - Multiple Sclerosis Ms News Today

A new study suggests individuals with a history of prior hospitalization for substance use disorder could be twice as likely to die from other medical conditions.

In a large, retrospective cohort study, investigators found a slightly increased risk for MS in patients on TNF therapy, especially among those being treated for rheumatic disease.

Autologous hematopoietic stem cell therapy does not outperform disease-modifying therapy in patients with multiple sclerosis, two new studies suggest.

The top 3 things you should know to start your day.

New research goes "a step further" than previous studies by revealing a population of T cells in multiple sclerosis that may be responding directly to EBV during active viral disease, experts say.

An internet-based approach for providing cognitive-behavioral therapy reduces depressive symptoms, which are common in patients with multiple sclerosis.

Breastfeeding by women with MS or NMSOD who are taking anti-CD20 IgG1 monoclonal antibodies appears to be safe for infants, new research suggests.

Nondisabling relapses within 2 years of a multiple sclerosis diagnosis is linked to disability accumulation, and supports early use of high-efficacy, disease-modifying therapies, new research suggests.

New data from SPRINT-MS show that the drug has beneficial effects on slowly evolving lesions in people with multiple sclerosis, perhaps by abrogating chronic active lesions.

Although serum glial fibrillary acid protein (GFAP) could be a useful complement to the multiple sclerosis biomarker neurofilament light chain (NfL), it is not ready for the clinic, experts say.